Free light chains of immunoglobulins in the cerebrospinal fluid of human immunodeficiency virus type 1-infected patients
暂无分享,去创建一个
[1] J. L. Nielsen,et al. Free light chains of immunoglobulins in serum from patients with leukaemias and multiple myeloma. , 2009, Scandinavian journal of haematology.
[2] B. Tavolato,et al. Immunoglobulin light chain patterns in the cerebrospinal fluid A study with special reference to the occurrence of free light chains in cerebrospinal fluid with and without oligoclonal immunoglobulin G , 1989, Journal of the Neurological Sciences.
[3] F. Brun-Vézinet,et al. Immunoglobulins and complement components in 37 patients infected by HIV-1 virus: Comparison of general (systemic) and intrathecal immunity , 1989, Journal of the Neurological Sciences.
[4] B. Tavolato,et al. Intrathecal Synthesis of Anti‐HIV Oligoclonal IgG in HIV‐Seropositive Patients Having No Signs of HIV‐Induced Neurologic Diseases , 1988, Annals of the New York Academy of Sciences.
[5] V. ter meulen,et al. Comparative analysis of virus-specific antibodies and immunoglobulins in serum and cerebrospinal fluid of subacute measles virus-induced encephalomyelitis (SAME) in rats and subacute sclerosing panencephalitis (SSPE) , 1988, Journal of Neuroimmunology.
[6] C. Blomstrand,et al. Increasing intrathecal lymphocytosis and immunoglobulin G production in neurologically asymptomatic HIV-1 infection , 1988, Journal of Neuroimmunology.
[7] F. Chiodi,et al. Human immunodeficiency virus infection of the brain II. Detection of intrathecally synthesized antibodies by enzyme linked immunosorbent assay and imprint immunofixation , 1988, Journal of the Neurological Sciences.
[8] I. Elovaara,et al. Intrathecal humoral immunologic response in neurologically symptomatic and asymptomatic patients with human immunodeficiency virus infection , 1988, Neurology.
[9] M. Moroni,et al. Oligoclonai IgG bands in cerebrospinal fluid and serum during asymptomatic human immunodeficiency virus infection , 1988, Annals of neurology.
[10] M. Gurney,et al. Restricted heterogeneity of antibody to gp120 and p24 in AIDS. , 1988, Journal of immunology.
[11] B. Tavolato,et al. Cerebrospinal fluid lymphocytes from HIV-infected patients synthesize HIV-specific antibody in vitro , 1988, Journal of Neuroimmunology.
[12] S. Zolla-Pazner,et al. B-cell activation in HIV infection: relationship of spontaneous immunoglobulin secretion to various immunological parameters. , 1988, Clinical and experimental immunology.
[13] B. Tavolato,et al. Blood-brain barrier damage restricts the reliability of quantitative formulae and isoelectric focusing in detecting intrathecally synthesized IgG , 1988, Journal of the Neurological Sciences.
[14] L. Resnick,et al. Early penetration of the blood‐brain‐barrier by HIV , 1988, Neurology.
[15] H. P. Fell,et al. An immunoglobulin light chain dimer with CD4 antigen specificity. , 1987, Molecular immunology.
[16] C. DeCarli,et al. Free light chains in multiple sclerosis and infections of the CNS , 1987, Neurology.
[17] R. Schooley,et al. Subacute encephalomyelitis of AIDS and its relation to HTLV‐III infection , 1987, Neurology.
[18] D. Heiner,et al. Isolated IgG4 subclass deficiency and malignant lymphoma in a child with acquired immunodeficiency syndrome. , 1987, American journal of diseases of children.
[19] H. Reiber,et al. Protein transfer at the blood cerebrospinal fluid barrier and the quantitation of the humoral immune response within the central nervous system. , 1987, Clinica chimica acta; international journal of clinical chemistry.
[20] R. Davis,et al. Primary central nervous system lymphoma in acquired immune deficiency syndrome: A clinical and pathological study , 1986, Annals of neurology.
[21] S. B. Schotters,et al. Triclonal gammopathy in a patient with AIDS. , 1986, Clinical chemistry.
[22] B. Tavolato,et al. Search for HTLV‐I and LAV/HTLV‐III antibodies in serum and CSF of multiple sclerosis patients , 1986, Acta neurologica Scandinavica.
[23] J. E. Hopper,et al. Evidence by radioimmunoassay that mitogen-activated human blood mononuclear cells secrete significant amounts of light chain Ig unassociated with heavy chain. , 1986, Cellular immunology.
[24] R. Herndon,et al. Free kappa light chains in multiple sclerosis spinal fluid , 1986, Annals of neurology.
[25] A. Del Mistro,et al. HTLV-III and HTLV-I infection in populations at risk in the Veneto region of Italy. , 1986, European journal of cancer & clinical oncology.
[26] R. Redfield,et al. The Walter Reed staging classification for HTLV-III/LAV infection. , 1986, The New England journal of medicine.
[27] D. Ho,et al. Intra-blood-brain-barrier synthesis of HTLV-III-specific IgG in patients with neurologic symptoms associated with AIDS or AIDS-related complex. , 1985, The New England journal of medicine.
[28] E. Thompson,et al. Free light chains in the cerebrospinal fluid: an indicator of recent immunological stimulation. , 1985, Journal of neurology, neurosurgery, and psychiatry.
[29] J. Parker,et al. Primary central nervous system lymphoma in homosexual men. Clinical, immunologic, and pathologic features. , 1985, The American journal of medicine.
[30] D. Bredesen,et al. Neurological manifestations of the acquired immunodeficiency syndrome (AIDS): experience at UCSF and review of the literature. , 1985, Journal of neurosurgery.
[31] E. Gelmann,et al. Oligoclonal immunoglobulins in patients with the acquired immunodeficiency syndrome. , 1985, Clinical immunology and immunopathology.
[32] T. Olsson,et al. Improved detection of oligoclonal IgG in cerebrospinal fluid by isoelectric focusing in agarose, double-antibody peroxidase labeling, and avidin-biotin amplification. , 1984, Clinical chemistry.
[33] A. Fauci,et al. High incidence of free monoclonal lambda light chains in the sera of patients with Sjogren's syndrome. , 1983, Journal of immunology.
[34] E. Norrby,et al. Intrathecal synthesis of virus-specific oligoclonal IgG, IgA and IgM antibodies in a case of varicella-zoster meningoencephalitis , 1982, Journal of the Neurological Sciences.
[35] S. Zolla-Pazner,et al. Disseminated Kaposi's sarcoma in homosexual men. , 1982, Annals of internal medicine.
[36] E. Norrby,et al. Mumps meningitis: Specific and non‐specific antibody responses in the central nervous system * , 1982, Acta neurologica Scandinavica.
[37] E. Norrby,et al. Neurosyphilis: Intrathecal synthesis of oligoclonal antibodies to treponema pallidum , 1982, Annals of neurology.
[38] M. Gottlieb,et al. Pneumocystis carinii pneumonia and mucosal candidiasis in previously healthy homosexual men: evidence of a new acquired cellular immunodeficiency. , 1981, The New England journal of medicine.
[39] S. Kam‐Hansen,et al. Oligoclonal IgG and free light chains in multiple sclerosis demonstrated by thin‐layer polyacrylamide gel isoelectric focusing and immunofixation , 1980, Annals of neurology.
[40] S. Ohman,et al. Principles of albumin and IgG analyses in neurological disorders. I. Establishment of reference values. , 1977, Scandinavian journal of clinical and laboratory investigation.
[41] U. K. Laemmli,et al. Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.
[42] A. Williamson,et al. Biosynthesis of Immunoglobulins. Free Light Chain as an Intermediate in the Assembly of γG-Molecules , 1966, Nature.
[43] J. Maizel,et al. Synthesis of Excess Light Chains of Gamma Globulin by Rabbit Lymph Node Cells , 1966, Nature.
[44] D. Bredesen,et al. Central nervous system dysfunction in acquired immunodeficiency syndrome. , 1988, Journal of acquired immune deficiency syndromes.
[45] B. Tavolato,et al. Central nervous system involvement in HIV infection. , 1988, AIDS research and human retroviruses.
[46] B. Tavolato,et al. Improved detection of free light chains in unconcentrated CSF by agarose IEF and avidin-biotin-peroxidase staining. , 1986 .
[47] N. Rabinovitch,et al. Oligoclonal Immunoglobutins, Light Chain Ratios and Free Light Chains in Cerebrospinal Fluid and Serum from Patients Affected with Various Neurological Diseases , 1978, Journal of clinical chemistry and clinical biochemistry. Zeitschrift fur klinische Chemie und klinische Biochemie.